Form 4: Hims & Hers CFO Okupe Reports Routine Equity Transactions

Hims & Hers Health, Inc. CFO Oluyemi Okupe reported routine equity transactions, including RSU vesting and shares withheld for tax obligations.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), reported transactions involving Class A Common Stock on March 13, 2026.
• A total of 226,081 shares of Class A Common Stock were withheld by the issuer at a price of $24.77 per share to cover tax withholding obligations related to the vesting and settlement of performance restricted stock units (RSUs) that vested on February 23, 2026.
• An additional 57,909 shares of Class A Common Stock were withheld by the issuer at a price of $24.77 per share to cover tax withholding obligations in connection with the reported vesting and settlement of other RSUs.
• Okupe acquired 105,200 shares of Class A Common Stock through the settlement of various Restricted Stock Units (RSUs).
• Following these transactions, Okupe directly beneficially owns 323,517 shares of Class A Common Stock.
• Okupe also indirectly beneficially owns 7,853 shares of Class A Common Stock held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
• Several tranches of Restricted Stock Units (RSUs) were exercised/converted, totaling 105,200 shares, with remaining unvested RSUs totaling 395,033 across different vesting schedules.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It represents a routine executive compensation transaction (RSU vesting and tax withholding) and does not indicate any new positive or negative developments regarding the company's operational or financial performance.

Positives

• The vesting of Restricted Stock Units (RSUs) represents the realization of equity compensation for the Chief Financial Officer, indicating a component of their compensation package is being delivered.
• The acquisition of 105,200 shares of Class A Common Stock through RSU settlement increases the CFO's direct ownership in the company, aligning their interests with shareholders.

Negatives

• A total of 283,990 shares of Class A Common Stock were disposed of to cover tax withholding obligations, which reduces the direct shareholding of the Chief Financial Officer, although this is a standard practice for equity compensation.

Future Outlook

The filing indicates ongoing equity compensation through Restricted Stock Units (RSUs) with various service-based vesting requirements extending into future quarterly installments. This suggests a continued long-term incentive structure for the Chief Financial Officer.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and subsequent tax-related share disposals, are common across publicly traded companies, particularly in growth-oriented sectors like digital health. These transactions typically reflect pre-scheduled compensation events rather than discretionary trading based on new company developments.

Comparison to Industry Standards

• The practice of withholding shares to cover tax obligations upon RSU vesting is a standard industry practice for executive equity compensation, aligning with common compensation structures seen in technology and healthcare companies globally.
• The multi-year service-based vesting schedules for RSUs are typical for executive compensation plans, designed to retain talent and align long-term interests, comparable to practices at companies like Teladoc Health (TDOC) or GoodRx (GDRX) in the digital health space.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are routine compensation-related transactions and do not signal a change in company fundamentals or strategy.
• Employees: Reflects the standard equity compensation practices for executives, which can be a benchmark for broader employee equity programs.

Next Steps

• Continued vesting of remaining Restricted Stock Units (RSUs) on specified Company Quarterly Vesting Dates (March 15, June 15, September 15, and December 15).

Key Dates

Keywords

Hims & Hers Health, HIMS, Oluyemi Okupe, CFO, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Equity Compensation, Stock Withholding, Beneficial Ownership